From compliance to commitment: India Pharma Inc’s safety reckoning
A spate of fatal incidents at pharma plants has exposed critical gaps in workplace safety. With growing ESG scrutiny and global…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharma sector records higher deal value in November 2025
GlobalData data shows increases in mergers, acquisitions and venture funding activity year-on-year
Immutep and Dr Reddy’s enter Exclusive Licensing Agreement for Eftilagimod Alfa
Deal covers commercialisation and development rights outside key regulated markets
Anuh Pharma receives Certificate of Suitability from EDQM for Sulfadimethoxine
Company shares regulatory milestone and product details
Satya Karm Punia joins Putin’s India visit as part of official business delegation
Indian-origin pharma leader represented Russia in bilateral trade discussions
Senores Pharmaceuticals receives Philippine FDA approval for 10 products
Company expands presence in Southeast Asia with new regulatory clearances
Lupin receives tentative U.S. FDA approval for Siponimod Tablets
Approval covers 0.25 mg, 1 mg and 2 mg strengths for multiple sclerosis treatment
Medley launches Biscal D –Calcium and Vitamin D3 fortified biscuit
Medley expands nutraceutical portfolio with fortified biscuit offering
Lupin signs exclusive licensing agreement with Valorum Biologics for Armlupeg in the U.S.
Companies outline roles in manufacturing, commercialisation and distribution
Granules India reports completion of FDA inspection with zero observations
Granules India outlines the inspection outcome and operational role of its U.S. subsidiary